Eribulin Mesylate

Eribulin Mesylate
Product Description

Eribulin (E7389) mesylate is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin mesylate inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.

Read more Show less

Chongqing Sintaho Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
View company profile

Chongqing Sintaho Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
View company profile

More Products from Chongqing Sintaho Pharmaceutical Co., Ltd. (4)

  • Deruxtecan

    Product Deruxtecan

    Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.
  • Exatecan Mesylate

    Product Exatecan Mesylate

    Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research.
  • MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH

    Product MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH

    MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • Paclitaxel

    Product Paclitaxel

    Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy.